AmitRMehtaMD

PubMed

• 6 citations
  Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk.
  Amit R Mehta, Aron Kefela, Charina Toste, Donald Sweet> ;Acta Haematologica. 2021 Dec 14
• 2 citations
  Fostamatinib disodium hexahydrate: a novel treatment for adult immune thrombocytopenia.
  Ali McBride, Pratima Nayak, Yuliya Kreychman, Leslie Todd, Anne-Marie Duliege, Amit R Mehta> ;The American Journal of Managed Care. 2019 Nov 1
• Tasquinimod in the treatment of castrate-resistant prostate cancer - current status and future prospects.
  Mehta, A. R.,Armstrong, A. J.> ;Ther Adv Urol. 2016 Feb 03
• Orteronel plus prednisone in patients with chemotherapy-naive metastatic castration-resistant prostate cancer (ELM-PC 4): a double-blind, multicentre, phase 3, randomi...
  Saad F, Fizazi K, Jinga V, Efstathiou E, Fong PC, Hart LL, Jones R, McDermott R, Wirth M, Suzuki K, MacLean DB, Wang L, Akaza H, Nelson J, Scher HI, Dreicer R, Webb IJ...> ;The Lancet. Oncology. 2015-02-18
• Targeting the glucose-regulated protein-78 abrogates Pten-null driven AKT activation and endometrioid tumorigenesis.
  Lin, Y. G.,Shen, J.,Yoo, E.,Liu, R.,Yen, H. Y.,Mehta, A.,Rajaei, A.,Yang, W.,Mhawech-Fauceglia, P.,DeMayo, F. J.,Lydon, J.,Gill, P.,Lee, A. S.> ;Oncogene. 2015 Feb 17
• Patterns and correlates of prostate cancer treatment in older men.
  Roberts, C.B., Albertsen, P.C., Shao, Y., Moore, D.F., Mehta, A.R., Stein, M.N., Lu-Yao, G.L.> ;Am J Med. 2011 Mar
• Risk profiles and treatment patterns among men diagnosed as having prostate cancer and a prostate-specific antigen level below 4.0 ng/ml.
  Shao, Y., Albertsen, P.C., Roberts, C.B., Lin, Y., Mehta, A.R., Stein, M.N., DiPaola, R.S., Lu-Yao, G.L.> ;Arch Intern Med. 2010 Jul 26
• Contemporary risk profile of prostate cancer in the United States.
  Shao, Y., Demissie, K., Shih, W., Mehta, A.R., Stein, M.N., Roberts, C.B., Dipaola, R.S., Lu-Yao, G.L.> ;J Natl Cancer Inst. 2009-09-16
• Join now to see all

Journal Articles

• Real-World Use of Fostamatinib in Patients with Immune Thrombocytopenia and Thrombotic Risk  
  Amit R Mehta, Aron Kefela, Charina Toste, Donald Sweet, Acta Haematologica, 3/1/2022
• Tasquinimod in the treatment of castrate-resistant prostate cancer - current status and future prospects  
  Amit R Mehta, Therapeutic Advances in Urology, 2/1/2016
• Stomatocytosis Heralding a Case of Acute Wilsonian Crisis  
  Mehta AR, Salaru G, Harrison JS, Annals of Hematology, 9/24/2010

Abstracts/Posters

• Differential Effects of Ferric Derisomaltose and Ferric Carboxymaltose on Fatigue in Patients with Iron Deficiency Anemia and Inflammatory Bowel Disease
  Amit R. Mehta, Myles Wolf, Heinz Zoller, 2022 American Society of Hematology Annual Conference, New Orleans, LA, 12/1/2022
• Phase Ib safety trial of CVX-060, an intravenous humanized monoclonal CovX body inhibiting angiopoietin 2 (Ang-2), with axitinib in patients with previously treated me...
  Mehta AR et al., American Society of Clinical Oncology (ASCO), Chicago, IL, 6/2013
• Stomatocytosis Heralding a Case of Acute Wilsonian Crisis: Case Report and Review of the Literature
  Mehta AR, Salaru G, Harrison JS, American Society of Hematology, New Orleans, LA, 12/2009
• Long-term Outcomes of Patients Treated with Docetaxel for Hormone-Dependent Prostate-Specific Antigen Progression after Local Therapy for Prostate Cancer
  Mehta AR, Anand R, Stein MN, Shih WJ, Goodin S, DiPaola RS, ASCO GU Symposium, San Francisco, CA, 2008
• A Phase II Trial of 13-cis Retinoic Acid, Interferon, Docetaxel, and Estramustine (RITE) for the Treatment of Hormone Refractory Prostate Cancer
  Mehta AR, Stein MN, DiPaola RS, et al., ASCO GU Symposium, Orlando, FL, 2007
• Pre-Treatment PSA Doubling Time (PSA DT) Predicts Biochemical Response to Chemotherapy in Patients with Androgen Sensitive PSA Progression after Local Therapy
  Mehta AR, Stein MN, Goodin S, Yao S, Shih J, DiPaola RS, ASCO GU Symposium, San Francisco, CA, 2006
• Join now to see all